These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38884167)

  • 21. miR-124-3p and miR-194-5p regulation of the PI3K/AKT pathway via ROR2 in medulloblastoma progression.
    Wang C; Fu R; Wang Y; Wei J; Yu Y; Hu L; Zhang C
    Cancer Gene Ther; 2024 Jun; 31(6):941-954. PubMed ID: 38632356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations.
    Okonechnikov K; Schrimpf D; Koster J; Sievers P; Milde T; Sahm F; Jones DTW; von Deimling A; Pfister SM; Kool M; Korshunov A
    Acta Neuropathol; 2024 Jun; 147(1):95. PubMed ID: 38847845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Unified Deep Learning Framework for Single-Cell ATAC-Seq Analysis Based on ProdDep Transformer Encoder.
    Wang Z; Zhang Y; Yu Y; Zhang J; Liu Y; Zou Q
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma: evidence for growth factor-thrombin cross-talk.
    D'Asti E; Kool M; Pfister SM; Rak J
    J Thromb Haemost; 2014 Nov; 12(11):1838-49. PubMed ID: 25163932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-cell chromatin accessibility reveals principles of regulatory variation.
    Buenrostro JD; Wu B; Litzenburger UM; Ruff D; Gonzales ML; Snyder MP; Chang HY; Greenleaf WJ
    Nature; 2015 Jul; 523(7561):486-90. PubMed ID: 26083756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting the genomic complexity underlying medulloblastoma.
    Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
    Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nkx2-2as Suppression Contributes to the Pathogenesis of Sonic Hedgehog Medulloblastoma.
    Zhang Y; Wang T; Wang S; Xiong Y; Zhang R; Zhang X; Zhao J; Yang AG; Wang L; Jia L
    Cancer Res; 2018 Feb; 78(4):962-973. PubMed ID: 29229597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Classification of Medulloblastoma.
    Kijima N; Kanemura Y
    Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging.
    Linke F; Johnson JEC; Kern S; Bennett CD; Lourdusamy A; Lea D; Clifford SC; Merry CLR; Stolnik S; Alexander MR; Peet AC; Scurr DJ; Griffiths RL; Grabowska AM; Kerr ID; Coyle B
    Acta Neuropathol Commun; 2023 Jan; 11(1):6. PubMed ID: 36631900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas.
    Wang YX; Wu H; Ren Y; Lv S; Ji C; Xiang D; Zhang M; Lu H; Fu W; Liu Q; Yan Z; Ma Q; Miao J; Cai R; Lan X; Wu B; Wang W; Liu Y; Wang DZ; Cao M; He Z; Shi Y; Ping Y; Yao X; Zhang X; Zhang P; Wang JM; Wang Y; Cui Y; Bian XW
    Signal Transduct Target Ther; 2022 Mar; 7(1):72. PubMed ID: 35273141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression.
    Schmidt C; Cohen S; Gudenas BL; Husain S; Carlson A; Westelman S; Wang L; Phillips JJ; Northcott PA; Weiss WA; Schwer B
    Sci Rep; 2024 Jul; 14(1):16074. PubMed ID: 38992221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggressive Medulloblastoma-Derived Exosomal miRNAs Promote In Vitro Invasion and Migration of Tumor Cells Via Ras/MAPK Pathway.
    Zhu LY; Wu XY; Liu XD; Zheng DF; Li HS; Yang B; Zhang J; Chang Q
    J Neuropathol Exp Neurol; 2020 Jul; 79(7):734-745. PubMed ID: 32417918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma.
    Martins-da-Silva A; Baroni M; Salomão KB; das Chagas PF; Bonfim-Silva R; Geron L; Cruzeiro GAV; da Silva WA; Corrêa CAP; Carlotti CG; de Paula Queiroz RG; Marie SKN; Brandalise SR; Yunes JA; Scrideli CA; Valera ET; Tone LG
    Cell Mol Neurobiol; 2023 Mar; 43(2):813-826. PubMed ID: 35366170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
    Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
    Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling medulloblastoma in vivo and with human cerebellar organoids.
    Ballabio C; Anderle M; Gianesello M; Lago C; Miele E; Cardano M; Aiello G; Piazza S; Caron D; Gianno F; Ciolfi A; Pedace L; Mastronuzzi A; Tartaglia M; Locatelli F; Ferretti E; Giangaspero F; Tiberi L
    Nat Commun; 2020 Jan; 11(1):583. PubMed ID: 31996670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATAC-STARR-seq reveals transcription factor-bound activators and silencers within chromatin-accessible regions of the human genome.
    Hansen TJ; Hodges E
    Genome Res; 2022 Aug; 32(8):1529-1541. PubMed ID: 35858748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma.
    Al-Halabi H; Nantel A; Klekner A; Guiot MC; Albrecht S; Hauser P; Garami M; Bognar L; Kavan P; Gerges N; Shirinian M; Roberge D; Muanza T; Jabado N
    Acta Neuropathol; 2011 Feb; 121(2):229-39. PubMed ID: 21107850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor cells generate astrocyte-like cells that contribute to SHH-driven medulloblastoma relapse.
    Guo D; Wang Y; Cheng Y; Liao S; Hu J; Du F; Xu G; Liu Y; Cai KQ; Cheung M; Wainwright BJ; Lu QR; Zhao Y; Yang ZJ
    J Exp Med; 2021 Sep; 218(9):. PubMed ID: 34254999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IGFBP2 promotes proliferation and cell migration through STAT3 signaling in Sonic hedgehog medulloblastoma.
    Kunhiraman H; McSwain L; Shahab SW; Gershon TR; MacDonald TJ; Kenney AM
    Acta Neuropathol Commun; 2023 Apr; 11(1):62. PubMed ID: 37029430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.
    Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C
    J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.